ESC Professional Premium Access

Meet the Experts: how to lower cardiovascular disease risk in patients with diabetes

Event: ESC Congress 2022
Topic: Cardiovascular Pharmacotherapy
Session type: Meet the Experts
Date: 29 August 2022
Time: 08:30 - 10:00

Congress Session

Become an ESC Professional member to access this resource

Become a member

Already a member? Sign in

5 presentations in this session

Assessment of risk in diabetic patients.

Speaker: Professor F. Cosentino (Stockholm, SE)
Thumbnail

All diabetic patients should be treated with GLP1 and/or GIP agonists.

Speaker: Professor A. Cahn (Jerusalem, IL)
Thumbnail

All diabetic patients should be treated with SGLT2 inhibitors.

Speaker: Associate Professor L. Mellbin (Stockholm, SE)
Thumbnail

All diabetic patients should be treated with metformin.

Speaker: Professor H. Drexel (Feldkirch, AT)
Thumbnail

Putting it all together: how to lower cardiovascular disease risk in patients with diabetes.

Speaker: Professor N. Marx (Aachen, DE)
Thumbnail

5 speakers from this session

Professor Francesco Cosentino

Unit of Cardiology, Karolinska Institute & Karolinska University Hospital, Stockholm (Sweden)
22 presentations
0 follower

Professor Avivit Cahn

Hadassah - Hebrew University Medical Center Jerusalem, Jerusalem (Israel)
2 presentations
0 follower

Associate Professor Linda Mellbin

Karolinska University Hospital, Stockholm (Sweden)
6 presentations
0 follower

Professor Heinz Drexel

Vorarlberg Institute for Vascular Investigation & Treatment (VIVIT), Feldkirch (Austria)
13 presentations
2 followers

Professor Nikolaus Marx

RWTH University Hospital Aachen, Aachen (Germany)
28 presentations
1 follower

This platform is supported by

logo Novo Nordisk